Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for chronic insomnia management in COPD patients
TCTR20251231001Phase 4Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lemborexant in insomnia, chronic obstructive pulmonary disease (COPD), sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
insomniachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on TCTR20251231001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251231001.